| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.680 | - | 3.834 | 1.596 | 5.647 | 5.411 | 5.198 | 5.653 | 5.358 | 5.648 |
| Total Income - EUR | 4.568 | - | 4.738 | 2.269 | 6.451 | 6.254 | 5.898 | 5.660 | 7.536 | 7.040 |
| Total Expenses - EUR | 3.970 | - | 7.930 | 5.366 | 6.212 | 5.587 | 6.078 | 9.253 | 12.822 | 15.183 |
| Gross Profit/Loss - EUR | 598 | - | -3.193 | -3.097 | 239 | 667 | -181 | -3.593 | -5.286 | -8.142 |
| Net Profit/Loss - EUR | 487 | - | -3.309 | -3.145 | 69 | 490 | -358 | -3.763 | -5.286 | -8.142 |
| Employees | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Implant Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 43.106 | - | 35.590 | 32.597 | 28.908 | 26.146 | 23.293 | 18.805 | 35.709 | 27.097 |
| Current Assets | 4.831 | - | 7.373 | 8.256 | 12.249 | 12.661 | 13.883 | 14.987 | 6.001 | 6.289 |
| Inventories | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 617 | - | 180 | 1.683 | 1.015 | 203 | 198 | 199 | 245 | 119 |
| Cash | 4.215 | - | 7.194 | 6.573 | 11.234 | 12.458 | 13.685 | 14.788 | 5.757 | 6.170 |
| Shareholders Funds | -37.132 | - | -41.677 | -44.057 | -43.135 | -41.963 | -41.391 | -45.282 | -50.430 | -58.291 |
| Social Capital | 45 | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 85.069 | - | 84.640 | 84.911 | 84.292 | 81.670 | 79.398 | 79.968 | 92.984 | 92.515 |
| Income in Advance | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Implant Med Srl